Cliffs' fair value estimate from $12.17 to $12.76 following the latest quarterly results. This adjustment is due to upgraded revenue forecasts and renewed confidence in the company's near-term ...
15h
How Investors Are Reacting To McKesson (MCK) Securing LYMPHIR’s Distribution Ahead of U.S. Launch
In October 2025, Citius Oncology announced a distribution services agreement with McKesson, making McKesson an authorized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback